Connaughton Bernadette sold HALO
June 1, 2026 · Form 4 insider transaction
Connaughton Bernadette sold 1,625 shares of Halozyme Therapeutics, Inc. at $66.21 per share, a transaction worth $107.6K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
1,625
Price
$66.21
Total value
$107.6K
InsiderConnaughton Bernadette
RoleDirector
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateJune 1, 2026
Filing dateJune 2, 2026
Shares owned after43,669
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The sales reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on May 29, 2025 in accordance with Rule 10b5-1.